CORC

在结果中检索

CORC

浏览/检索结果: 共37条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Predictive value of early molecular response for deep molecular response in chronic phase of chronic myeloid leukemia 期刊论文
MEDICINE, 2019, 卷号: 98, 期号: 15
作者:  Zhang, Chen;  Li, Caili;  Wang, Rui;  Cong, Yue;  Lin, Hai
收藏  |  浏览/下载：21/0  |  提交时间：2019/12/05
BW18, a C-21 steroidal glycoside, exerts an excellent anti-leukemia activity through inducing S phase cell cycle arrest and apoptosis via MAPK pathway in K562 cells. 期刊论文
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2019, 卷号: Vol.112, 页码: 108603
作者:  Jue Yang;  Li Chen;  Ying Yan;  Jianfei Qiu;  Juan Chen
收藏  |  浏览/下载：17/0  |  提交时间：2019/12/17
BW18  Cell  apoptosis  Cell  cycle  arrest  Chronic  myeloid  leukemia  MAPK  pathway  
Discovery of (E)-N-(4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)-3-((3-(2-(pyridin-2-yl)vinyl)-1H-indazol-6-yl)thio)propanamide (CHMFL-ABL-121) as a highly potent ABL kinase inhibitor capable of overcoming a variety of ABL mutants including T315I for chronic myeloid leukemia 期刊论文
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 卷号: 160, 页码: 61-81
作者:  Liu, Xuesong;  Wang, Beilei;  Chen, Cheng;  Jiang, Zongru;  Hu, Chen
收藏  |  浏览/下载：14/0  |  提交时间：2019/01/11
Comparison of Frequency and Sensitivity of BCR-ABL1 Kinase Domain Mutations in Asian and White Patients With Imatinib-resistant Chronice-Phase Chronic Myeloid Leukemia 期刊论文
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 卷号: 18, 期号: 10
作者:  Cui, Jiu Wei;  Kim, Hawk;  Kim, SooHyun;  Kim, Hyeoung-Joon;  Kim, Yeo-Kyeoung
收藏  |  浏览/下载：13/0  |  提交时间：2019/12/05
Dasatinib Versus Imatinib in Patients (Pts) with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Who Have Not Achieved an Optimal Response to 3 Months of Imatinib Therapy: Dascern 会议论文
BLOOD, 2018-11-29
作者:  Cortes, Jorge E.;  Jiang, Qian;  Wang, Jianxiang;  Weng, Jianyu;  Zhu, Huanling
收藏  |  浏览/下载：11/0  |  提交时间：2020/01/03
Dasatinib Versus Imatinib in Patients (Pts) with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Who Have Not Achieved an Optimal Response to 3 Months of Imatinib Therapy: Dascern 期刊论文
2018, 卷号: 132
作者:  Cortes, Jorge E.;  Jiang, Qian;  Wang, Jianxiang;  Weng, Jianyu;  Zhu, Huanling
收藏  |  浏览/下载：13/0  |  提交时间：2020/01/03
Puquitinib, a novel orally available PI3K inhibitor, exhibits potent antitumor efficacy against acute myeloid leukemia 期刊论文
CANCER SCIENCE, 2017, 卷号: 108, 期号: 7, 页码: 1476-1484
作者:  Xie, Chengying;  He, Ye;  Zhen, Mingyue;  Wang, Yulan;  Xu, Yongping
收藏  |  浏览/下载：18/0  |  提交时间：2019/01/08
Analysis of clinical characteristics and efficacy of chronic myeloid leukemia onset with extreme thrombocytosis in the era of tyrosine kinase inhibitors 期刊论文
ONCOTARGETS AND THERAPY, 2017, 卷号: 10
作者:  Liu, Zhihe;  Fan, Hongqiong;  Li, Yuying;  Liu, Chunshui
收藏  |  浏览/下载：11/0  |  提交时间：2019/12/05
Cytogenetic landscape and impact in blast phase of chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy 期刊论文
LEUKEMIA, 2017, 卷号: 31, 期号: 3
作者:  Chen, Z.;  Shao, C.;  Wang, W.;  Zuo, Z.;  Mou, X.
收藏  |  浏览/下载：9/0  |  提交时间：2019/12/05
Synthesis and Cytotoxicity against K562 Cells of 3-O-Angeloyl-20-O-acetyl Ingenol, a Derivative of Ingenol Mebutate 期刊论文
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 卷号: 17, 期号: 8
作者:  Liu, Ming;  Chen, Fangling;  Yu, Rilei;  Zhang, Weiyi;  Han, Mei
收藏  |  浏览/下载：6/0  |  提交时间：2019/08/19

©版权所有 ©2017 CSpace - Powered by CSpace